From Name:
From Email:
To Name:
To Email:

Optional Message:


StrataGraft regenerative tissue meets primary endpoints in phase 3 trial for thermal burns

from Healio

The biopharmaceutical company Mallinckrodt announced positive top-line results from its phase 3 clinical trial for StrataGraft regenerative tissue and plans to submit a biologics license application to the FDA in the first half of 2020. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063